Corrigendum to: Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis (Autoimmunity, (2018), 51, 1, (25-34), 10.1080/08916934.2018.1428956);Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis

Autoimmunity

Volumn 51, Issue 1, 2018, Pages 25-34

  Abd Elhalem, Sahar Sobhy ^a   Haggag, Nawal Zakaria ^a   El Shinnawy, Nashwa Ahmed ^a  

^a Ain Shams University   (Egypt)

Author keywords

adjuvant induced arthritis; bone marrow mesenchymal stem cells; hesperidin; Interleukin 9; spleen

Indexed keywords

ANTINUCLEAR ANTIBODY; FREUND ADJUVANT; GAMMA INTERFERON; GLUTATHIONE; HESPERIDIN; INTERLEUKIN 4; INTERLEUKIN 9; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARTILAGE INJURY; CONTROLLED STUDY; HISTOLOGY; IMMUNOMODULATION; INFLAMMATION; MALE; MEASUREMENT; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SPLEEN TISSUE; ALLOGRAFT; ANIMAL; BLOOD; BONE MARROW CELL; EXPERIMENTAL ARTHRITIS; IMMUNOLOGY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY;

ALLOGRAFTS; ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE MARROW CELLS; HESPERIDIN; INTERLEUKIN-9; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS;

EID: 85040967638     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916934.2018.1469295     Document Type: Erratum

References (59)

1. Gibofsky A., Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 2012;18:S295–S302.
2. Asquith DL, Miller AM, McInnes IB, et al. Animal models of rheumatoid arthritis. Eur J Immunol. 2009;39:2040–2044.
3. Vasanthi P, Nalini G, Rajasekhar G., Role of tumor necrosis factor‐alpha in rheumatoid arthritis: a review. APLAR J Rheum. 2007;10:270–274.
4. Bush KA, Walker JS, Lee CS, et al. Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol. 2001;123:487–495.
5. Sakuma M, Hatsushika K, Koyama K, et al. TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody. Int Immunol. 2007;19:117–126.
6. Ciccia F, Guggino G, Rizzo A, et al. Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2015;54:2264–2272.
7. Goswami R, Kaplan MH., A brief history of IL-9. J Immunol. 2011;186:3283–3288.
8. Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009;9:480.
9. Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med. 2009;206:1653–1660.
10. Dantas AT, Marques CD, da Rocha Junior LF, et al. Increased serum Interleukin-9 levels in rheumatoid arthritis and systemic lupus erythematosus: pathogenic role or just an epiphenomenon? Dis Markers. 2015;2015:519638.
11. Gaies E, Jebabli N, Trabelsi S, et al. Methotrexate side effects: review article. J Drug Metab Toxicol. 2012;3:125.
12. Robert EN, Dana Y, Michelle AL, et al. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets. 2009;8:110–123.
13. Wang L, Wang L, Cong X, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22:3192–3202.
14. Djouad F, Bouffi C, Ghannam S, et al. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol. 2009;5:392–399.
15. Li CJ, Chen PK, Sun LY, et al. Enhancement of mitochondrial transfer by antioxidants in human mesenchymal stem cells. Oxid Med Cell Longev. 2017;2017:8510805.
16. Bauerova K, Paulovicova E, Mihalova D, et al. Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukan in adjuvant arthritis. Toxicol Ind Health. 2009;25:329–335.
17. Kothari S, Thompson A, Agarwal A, et al. Free radicals: their beneficial and detrimental effects on sperm function. Indian J Exp Biol. 2010;48:425–435.
18. Parhiz H, Roohbakhsh A, Soltani F, et al. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 2015;29:323–331.
19. Mateen S, Moin S, Khan AQ, et al. Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis. PLoS One. 2016;11:e0152925.
20. Umar S, Kumar A, Sajad M, et al. Hesperidin inhibits collagen-induced arthritis possibly through suppression of free radical load and reduction in neutrophil activation and infiltration. Rheumatol Int. 2013;33:657–663.
21. Snekhalatha U, Anburajan M, Venkatraman B, et al. Evaluation of complete Freund’s adjuvant-induced arthritis in a Wistar rat model. Comparison of thermography and histopathology. Z Rheumatol. 2013;72:375–382.
22. Abdel Aziz MT, Atta HM, Mahfouz S, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem. 2007;40:893–899.
23. Abdel Aziz MT, El Asmar MF, Atta HM, et al. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. J Exp Clin Cancer Res. 2011;30:49.
24. Takano T, Li YJ, Kukita A, et al. Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis. Lab Invest. 2014;94:286–296.
25. Haasters F, Prall WC, Anz D, et al. Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat. 2009;214:759–767.
26. Ahmed YM, Messiha BA, Abo-Saif AA., Protective effects of simvastatin and hesperidin against complete freund’s adjuvant-induced rheumatoid arthritis in rats. Pharmacology. 2015;96:217–225.
27. Li Y, Wang S, Wang Y, et al. Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway. Transl Res. 2013;161:89–98.
28. Kehoe O, Cartwright A, Askari A, et al. Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritis. J Transl Med. 2014;12:157.
29. Satoh K., Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.
30. Beutler E, Duron O, Kelly BM., Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–888.
31. Nishikimi M, Appaji N, Yagi K., The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 1972;46:849–854.
32. Atkinson SM, Nansen A, Usher PA, et al. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model. Autoimmunity. 2015;48:460–470.
33. Kim EY, Chi HH, Rajaiah R, et al. Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis. Arthritis Res Ther. 2008;10:R38.
34. Chen Y, Wang QW, Zuo J, et al. Anti-arthritic activity of ethanol extract of Claoxylon indicum on Freund’s complete adjuvant-induced arthritis in mice. BMC Complement Altern Med. 2017;17:11.
35. Yang J, Li Q, Yang X, et al. Interleukin-9 is associated with elevated anti–double-stranded DNA antibodies in lupus-prone mice. Mol Med. 2015;21:364–370.
36. Ran C, Jian-hua X., The abnormality and clinical significance of T helper 9 cells and interleukin-9 in patients with rheumatoid arthritis. Chin J Rheumatol. 2012;16:442–445.
37. Rauber S, Luber M, Weber S, et al. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat Med. 2017;23:938–944.
38. Karagiannis F, Wilhelm C., More is less: IL-9 in the resolution of inflammation. Immunity. 2017;47:403–405.
39. Paludan SR., Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand J Immunol. 1998;48:459–468.
40. Mossiat C, Laroche D, Prati C, et al. Association between arthritis score at the onset of the disease and long-term locomotor outcome in adjuvant-induced arthritis in rats. Arthritis Res Ther. 2015;17:184.
41. IH S, TM E., A possible pathogenic role of CD4+ CD25+ T-regulatory cells in psoriasis. Egypt J Immunol. 2007;14:21–31.
42. Sun L, Wang D, Liang J, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010;62:2467–2475.
43. Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;11:1–2827.
44. Jung KH, Song SU, Yi T, et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology. 2011;140:998–1008.
45. Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol. 2006;177:2080–2087.
46. Francois M, Romieu-Mourez R, Li M, et al. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2012;20:187–195.
47. Gutcher I, Donkor MK, Ma Q, et al. Autocrine transforming growth factor-beta1 promotes in vivo Th17 cell differentiation. Immunity. 2011;34:396–408.
48. He Z, Hua J, Qian D, et al. Intravenous hMSCs ameliorate acute pancreatitis in mice via secretion of tumor necrosis factor-α stimulated gene/protein 6. Sci Rep. 2016;6:38438.
49. Peng Y, Chen X, Liu Q, et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia. 2015;29:636–646.
50. da Costa Goncalves F, Grings M, Nunes NS, et al. Antioxidant properties of mesenchymal stem cells against oxidative stress in a murine model of colitis. Biotechnol Lett. 2017;39:613–622.
51. Kemp K, Hares K, Mallam E, et al. Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. J Neurochem. 2010;114:1569–1580.
52. Ishii T, Mann GE., Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance. Redox Biol. 2014;2:786–794.
53. Chen MC, Ye YY, Ji G, et al. Hesperidin upregulates heme oxygenase-1 to attenuate hydrogen peroxide-induced cell damage in hepatic L02 cells. J Agric Food Chem. 2010;58:3330–3335.
54. Li R, Cai L, Ren D, et al. Therapeutic effect of 7, 3’-dimethoxy hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway. Int Immunopharmacol. 2012;14:157–163.
55. Li R, Cai L, Xie XF, et al. Hesperidin suppresses adjuvant arthritis in rats by inhibiting synoviocyte activity. Phytother Res. 2010;24:S71–S76.
56. Yeh CC, Kao SJ, Lin CC, et al. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 2007;80:1821–1831.
57. Yamamoto M, Jokura H, Hashizume K, et al. Hesperidin metabolite hesperetin-7-O-glucuronide, but not hesperetin-3′-O-glucuronide, exerts hypotensive, vasodilatory, and anti-inflammatory activities. Food Funct. 2013;4:1346–1351.
58. Nizamutdinova IT, Jeong JJ, Xu GH, et al. Hesperidin, hesperidin methyl chalone and phellopterin from Poncirus trifoliata (Rutaceae) differentially regulate the expression of adhesion molecules in tumor necrosis factor-α-stimulated human umbilical vein endothelial cells. Int Immunopharmacol. 2008;8:670–678.
59. Saiprasad G, Chitra P, Manikandan R, et al. Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis. Eur J Cancer. 2014;50:2489–2507.